Search Results for “EC” – Page 135 – media

AstraZeneca’s Durvalumab Receives Go-Ahead from DCGI to Market in India

Last Friday, pharma giant AstraZeneca announced that it had received the go-ahead from the Drug Controller General of India (DCGI) to import and market durvalumab (ImfinziTM) in India. The receipt of this permission paves the way for the launch of durvalumab (ImfinziTM) in India. Durvalumab which is a patented drug of Astra-Zeneca, received permission in India to provide treatment for patients with unresectable non-small cell lung cancer and metastatic urothelial carcinoma.
- Source: United News of India
- 2,547
- June 26, 2018
AstraZeneca cancer India New Approvals
Cotiviti Holdings Acquired by Verscend Technologies for $4.9 Billion

The new business with unique data-driven capabilities will work as a private healthcare IT company with a big impact in the health sector by reducing waste and improving quality outcomes and affordability as well as offering opportunities to create substantial value for clients.
- Source: Healthcare Global
- 744
- June 25, 2018
Company Insight health IT
Vitamin D Reduces Colorectal Cancer Risk

Previous research claimed that consumption of vitamin D rich foods can reduce the risk factors of colorectal cancer. There was no proper evidence available to link vitamin D levels and colorectal cancer. Now, new research led by the Harvard T.H. Chan School of Public Health, adds convincing evidence to authenticate the link.
- Source: HealthLine
- 2,507
- June 22, 2018
cancer Researches vitamin D
Boy Infected with Plague in Idaho

This is reported as the first case in Idaho in about 26 years and considered to be the fifth since 1940. During the middle ages, the plague was widespread across Europe, where nearly half of the population died. Hence it is also known as the ‘Black Death’.
- Source: Medical News Today
- 626
- June 22, 2018
Plague Researches
Heart Risk to be Detected by CRISPR

A new risk assessment tool combining gene editing technology CRISPR-Cas9 with stem cells using disease modeling techniques has been developed by a team of scientists at the Stanford University Cardiovascular Institute. The tool has facilitated the modeling of individual patients’ heart in a lab and enabled undertaking of tests to ascertain whether or not signs of diseases are displayed by cardiac cells, as per a statement by the American Heart Association.
- Source: Fierce Biotech
- 646
- June 19, 2018
American Heart Association CRISPR-Cas9 Researches
Water Fluoridation Prevents Dental Decay

With sufficient evidence, it was proved that community water fluoridation would provide proper dental health benefits for children and adolescents in the U.S. It is this advised to start consuming fluoridated drinking water as early as possible, anywhere between the ages of 2-8 years.
- Source: ScienceDaily
- 549
- June 19, 2018
health tips Researches
Precision Medicine – An Ultimate Panacea

Precision medicine is an emerging approach for disease treatment where genes, the environment and lifestyle of each person is taken into account.
- Source: FierceHealthcare
- 571
- June 19, 2018
DNA precision medicine Researches
Artificial Mole to Detect Early Cancer

In response to this challenge, an innovative new warning implant system has been developed to detect four common cancers (lung, prostate, breast and colon). The level of calcium in a person’s blood would constantly be checked and if the calcium levels are too high, it warns the patient about the cancer onset by growing an artificial mole on the person’s skin.
- Source: New Atlas
- 722
- June 15, 2018
cancer detection Researches skin cancer
Alta Partners Raise $130 Million Venture Capital for Biotech Development

San Francisco based Healthcare venture capital firm Alta Partners has launched funds titled as Alta Partner NextGen Fund I. The new fund will focus on the new development of therapeutics and health technology services. This will be the 9th fund in Alta Partners firms History.
- Source: FierceBiotech
- 614
- June 14, 2018
Company Insight healthcare technologies and innovations
FDA Considering Comments on SaMD Precertification Program

Healthcare industry stakeholders say the FDA should consider a type of measuring stick when evaluating a vendor’s cybersecurity culture to decide whether it meets the requirements for the agency’s proposed fast-past program for premarket approval of "software as a medical device" products (SaMD). Until the end of the last month, the FDA accepted proposals on its working model for a SaMD pre-approval program
- Source: Healthcare Info Security
- 725
- June 14, 2018
digital health FDA Market Views medical device

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.